✦ LIBER ✦

Prostate-Specific Antigen Level at Initiation of Hormonal Therapy After Prostate-Specific Antigen Failure Following Prostatectomy or Radiotherapy and Therapeutic Response

✍ Scribed by Brian M. Alexander; Ming-Hui Chen; Peter Carroll; Anthony V. D’Amico

Book ID: 116947486
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 76 KB
Volume: 70
Category: Article
ISSN: 0090-4295
DOI: 10.1016/j.urology.2007.03.074

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prostate-Specific Antigen Kinetics After

Prostate-Specific Antigen Kinetics After Brachytherapy or External Beam Radiotherapy and Neoadjuvant Hormonal Therapy

✍ Michael Pinkawa; Karin Fischedick; Marc D. Piroth; Bernd Gagel; Holger Borchers; 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 81 KB

Rosiglitazone versus placebo for men wit

Rosiglitazone versus placebo for men with prostate carcinoma and a rising serum prostate-specific antigen level after radical prostatectomy and/or radiation therapy

✍ Matthew R. Smith; Judith Manola; Donald S. Kaufman; Daniel George; William K. Oh 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 88 KB 👁 1 views

## Abstract ## BACKGROUND The objective of this study was to assess the biologic activity of rosiglitazone, a peroxisome proliferator‐activated receptor γ agonist that has been approved to treat type 2 diabetes, in men with recurrent prostate carcinoma using change in prostate specific antigen (PS

Time to Prostate-Specific Antigen Nadir

Time to Prostate-Specific Antigen Nadir After Androgen Suppression Therapy for Postoperative or Postradiation PSA Failure and Risk of Prostate Cancer-Specific Mortality

✍ Christine S. Chung; Ming-Hui Chen; Jennifer Cullen; David McLeod; Peter Carroll; 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 291 KB

Initial decline in hemoglobin during neo

Initial decline in hemoglobin during neoadjuvant hormonal therapy predicts for early prostate specific antigen failure following radiation and hormonal therapy for patients with intermediate and high-risk prostate cancer

✍ Anthony V. D'Amico; Tara Saegaert; Ming-Hui Chen; Andrew A. Renshaw; Daniel Geor 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB 👁 1 views

## Abstract ## BACKGROUND Declines in serum hemoglobin (Hgb) levels occur from the use of androgen suppression therapy (AST) in the treatment of prostate cancer patients. We studied whether time to prostate specific antigen (PSA) failure following external beam radiation therapy (RT) and AST could

Chemoprevention trials in men with prost

Chemoprevention trials in men with prostate-specific antigen failure or at high risk for recurrence after radical prostatectomy: Application to efficacy assessment of soy protein

✍ Maarten C Bosland; Ikuko Kato; Jonathan Melamed; Samir Taneja; Herbert Lepor; Pa 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 100 KB

Prostate carcinoma detection and increas

Prostate carcinoma detection and increased prostate-specific antigen levels after 4 years in Dutch and Japanese males who had no evidence of disease at initial screening

✍ Kazuto Ito; René Raaijmakers; Monique Roobol; Mark Wildhagen; Hidetoshi Yamanaka 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB

## Abstract ## BACKGROUND In the current study, the authors set out to investigate the possibility that increased prostate‐specific antigen (PSA) levels in Dutch and Japanese men without suspicious findings at initial prostate cancer screening were indicative of the risk of newly developing clinic